Literature DB >> 8581003

Keratinocyte growth factor: an androgen-regulated mediator of stromal-epithelial interactions in the prostate.

D M Peehl1, J S Rubin.   

Abstract

Members of the fibroblast growth factor (FGF) family are important growth-regulatory elements. Of the FGFs, keratinocyte growth factor (KGF) appears to have unique properties that implicate it as a paracrine factor in the prostate. Two KGF transcripts (approximately to 2.4 and 5.0 kb) encode a protein of approximately 22 kDa. In contrast to several other members of the FGF family, KGF has a signal peptide and is actively secreted. Cellular response to KGF is mediated by a specific receptor that is transcribed from an alternately spliced variant of the FGF type 2 receptor (FGFR-2). KGF transcripts have been detected in prostatic tissues and in stromal cells cultured from rat and human prostates as well as in a variety of stromal cells derived from other organs. Prostatic epithelial cells and numerous other types of epithelial cells are targets of KGF's mitogenic activity. Several factors involved in wound healing regulate the expression of KGF, but androgen regulation of KGF is of greatest relevance to the role of KGF in the prostate. Current efforts to localize and manipulate KGF activity in vivo should reveal the significance of KGF expression and function in the prostate and in other organs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581003     DOI: 10.1007/bf00185975

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  41 in total

Review 1.  Fibroblast growth factors: what's in a name?

Authors:  A Baird
Journal:  Endocrinology       Date:  1993-02       Impact factor: 4.736

2.  Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts.

Authors:  M Brauchle; K Angermeyer; G Hübner; S Werner
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

3.  Fibroblast growth factor receptor 4 is a high affinity receptor for both acidic and basic fibroblast growth factor but not for keratinocyte growth factor.

Authors:  D Ron; R Reich; M Chedid; C Lengel; O E Cohen; A M Chan; G Neufeld; T Miki; S R Tronick
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

4.  Emergence of the keratinocyte growth factor multigene family during the great ape radiation.

Authors:  M J Kelley; M Pech; H N Seuanez; J S Rubin; S J O'Brien; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

5.  Keratin immunoreactivity in the benign and neoplastic human prostate.

Authors:  M K Brawer; D M Peehl; T A Stamey; D G Bostwick
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

6.  Keratinocyte growth factor and fibroblast growth factor action on DNA synthesis in rat and human hepatocytes: modulation by heparin.

Authors:  A J Strain; G McGuinness; J S Rubin; S A Aaronson
Journal:  Exp Cell Res       Date:  1994-02       Impact factor: 3.905

7.  Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene.

Authors:  T Miki; D P Bottaro; T P Fleming; C L Smith; W H Burgess; A M Chan; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

8.  Expression of biologically active recombinant keratinocyte growth factor. Structure/function analysis of amino-terminal truncation mutants.

Authors:  D Ron; D P Bottaro; P W Finch; D Morris; J S Rubin; S A Aaronson
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

9.  Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen.

Authors:  S M Chang; L W Chung
Journal:  Endocrinology       Date:  1989-11       Impact factor: 4.736

10.  Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice.

Authors:  L Guo; Q C Yu; E Fuchs
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more
  12 in total

1.  Keratinocyte growth factor-induced motility of breast cancer cells.

Authors:  X P Zang; J T Pento
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  The differential effects of prostate stromal cells derived from different zones on prostate cancer epithelial cells under the action of sex hormones.

Authors:  Qi Jiang; Bang-Min Han; Fu-Jun Zhao; Yan Hong; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2011-07-18       Impact factor: 3.285

3.  Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium.

Authors:  M Stanbrough; I Leav; P W Kwan; G J Bubley; S P Balk
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

4.  Estrogen mitogenic action. ii. negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications.

Authors:  D A Sirbasku; J E Moreno-Cuevas
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Jul-Aug       Impact factor: 2.416

5.  Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor.

Authors:  A Chott; Z Sun; D Morganstern; J Pan; T Li; M Susani; I Mosberger; M P Upton; G J Bubley; S P Balk
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

6.  NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.

Authors:  David C Austin; Douglas W Strand; Harold L Love; Omar E Franco; Magdalena M Grabowska; Nicole L Miller; Omar Hameed; Peter E Clark; Robert J Matusik; Ren J Jin; Simon W Hayward
Journal:  Prostate       Date:  2016-05-16       Impact factor: 4.104

7.  Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase.

Authors:  Katsumi Shigemura; Shuji Isotani; Ruoxiang Wang; Masato Fujisawa; Akinobu Gotoh; Fray F Marshall; Haiyen E Zhau; Leland W K Chung
Journal:  Prostate       Date:  2009-06-15       Impact factor: 4.104

8.  Intraurethral injection with LPS: an effective experimental model of prostatic inflammation.

Authors:  Fabiana Oliveira Dos Santos Gomes; Amanda Costa Oliveira; Edlene Lima Ribeiro; Bruna Santos da Silva; Laise Aline Martins Dos Santos; Ingrid Tavares de Lima; Amanda Karolina Soares E Silva; Shyrlene Meiry da Rocha Araújo; Terezinha Gonçalves; Mario Ribeiro de Melo-Junior; Christina Alves Peixoto
Journal:  Inflamm Res       Date:  2017-11-18       Impact factor: 4.575

Review 9.  Androgen receptor roles in the development of benign prostate hyperplasia.

Authors:  Kouji Izumi; Atsushi Mizokami; Wen-Jye Lin; Kuo-Pao Lai; Chawnshang Chang
Journal:  Am J Pathol       Date:  2013-04-06       Impact factor: 4.307

Review 10.  2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology.

Authors:  Richard J Epstein; Li Jun Tian; Yan Fei Gu
Journal:  J Oncol       Date:  2021-04-30       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.